查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1387732

2024 年神經刺激設備全球市場報告

Neurostimulation Devices Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

2023年全球神經刺激設備市場最大的地區是北美。亞太地區是神經刺激設備市場的第二大地區。神經刺激設備市場報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

目錄

第1章 執行摘要

第2章 神經刺激設備市場特點

第3章 神經刺激設備市場趨勢與策略

第4章 神經刺激設備市場－宏觀經濟情勢

  • 高通膨對神經刺激設備市場的影響
  • 烏克蘭與俄羅斯戰爭對神經刺激設備市場的影響
  • COVID-19 對神經刺激設備市場的影響

第5章 全球神經刺激設備市場規模與成長

  • 全球神經刺激設備市場的驅動與抑制因素
    • 市場驅動力
    • 市場抑制因素
  • 2018-2023年全球神經刺激設備市場規模實績與成長
  • 2023-2028、2033年全球神經刺激設備市場規模及成長預測

第6章 神經刺激設備市場區隔

  • 全球神經刺激設備市場，依產品、實績及預測區隔，2018-2023、2023-2028、2033
  • 植入式裝置
  • 外部設備
  • 全球神經刺激設備市場，依應用、實績和預測區隔，2018-2023、2023-2028、2033
  • 疼痛管理
  • 癲癇
  • 自發性震顫
  • 尿失禁和大便失禁
  • 憂鬱症
  • 肌張力失調
  • 胃輕癱
  • 帕金森氏症
  • 全球神經刺激設備市場，依最終用戶區隔，實績和預測，2018-2023、2023-2028、2033
  • 醫院
  • 復健中心
  • 診所

第7章 神經刺激設備市場區域與國家分析

  • 全球神經刺激設備市場，依地區、實績和預測，2018-2023、2023-2028、2033
  • 全球神經刺激設備市場，依國家、實績及預測，2018-2023、2023-2028、2033

第8章 亞太神經神經刺激設備市場

第9章 中國神經刺激設備市場

第10章 印度神經刺激設備市場

第11章日本神經刺激設備市場

第12章澳洲神經刺激設備市場

第13章印尼神經刺激設備市場

第14章韓國神經刺激設備市場

第15章西歐神經刺激設備市場

第16章英國神經刺激設備市場

第17章德國神經刺激設備市場

第18章法國神經刺激設備市場

第19章義大利神經刺激設備市場

第20章西班牙神經刺激設備市場

第21章東歐神經刺激設備市場

第22章俄羅斯神經刺激設備市場

第23章北美神經刺激設備市場

第24章美國神經刺激設備市場

第25章加拿大神經刺激設備市場

第26章南美神經刺激設備市場

第27章巴西神經刺激設備市場

第28章中東神經刺激設備市場

第29章非洲神經刺激設備市場

第30章神經刺激設備市場的競爭形勢與公司概況

  • 神經刺激設備市場競爭形勢
  • 神經刺激設備市場公司概況
    • Medical Clinics
    • Medtronic plc
    • Cyberonics Inc.
    • Boston Scientific Corporation
    • Abbott Laboratories

第31章全球神經刺激設備市場競爭基準化分析

第32章全球神經刺激設備市場競爭儀表板

第33章神經刺激設備市場主要併購

第34章神經刺激設備市場未來前景及潛力分析

第35章附錄

簡介目錄
Product Code: r8974

“Neurostimulation Devices Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neurostimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neurostimulation devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The neurostimulation devices market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Implantable Devices; External Devices
  • 2) By Application: Pain Management; Epilepsy; Essential Tremor; Urinary and Fecal Incontinence; Depression; Dystonia; Gastroparesis; Parkinson's Disease
  • 3) By End User: Hospitals; Rehabilitation Centers; Medical Clinic
  • Sub-Segments Covered:
  • By Implantable Devices: Cochlear Implants; Deep Brain Stimulation; Spinal Cord Stimulation; Vagus Nerve Stimulation; Sacral Nerve Stimulation; Gastric Electric Stimulation 5) By External Devices: Transcranial Magnetic Stimulation (TMS); Transcutaneous Electrical Nerve Stimulation (TENS)
  • Companies Mentioned: Medtronic plc; Cyberonics Inc.; Boston Scientific Corporation; Abbott Laboratories; Nevro Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Neurostimulation devices are specialized medical devices that are implantable and programmable. They deliver low-voltage electrical impulses to specific nerves or targets within the spinal cord or brain, with the aim of influencing neuronal transmissions. This procedure is employed to treat or modulate motor functions and manage various medical conditions, including neuropathic pain, chronic pain, major treatment-resistant depression, Parkinson's disease, epilepsy, incontinence, gastroparesis, and essential tremor.

The primary products in the neurostimulation devices market can be categorized into implantable devices and external devices. Implantable devices include cochlear implants, deep brain stimulation devices, spinal cord stimulation devices, vagus nerve stimulation devices, sacral nerve stimulation devices, and gastric electric stimulation devices. External devices encompass transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). These devices are used in a variety of applications, including pain management, epilepsy, essential tremor, urinary and fecal incontinence, depression, dystonia, gastroparesis, and Parkinson's disease. They are employed by different healthcare facilities, such as hospitals, rehabilitation centers, and medical clinics.

The neurostimulation device market research report is one of a series of new reports from The Business Research Company that provides neurostimulation device market statistics, including neurostimulation device industry global market size, regional shares, competitors with a neurostimulation device market share, detailed neurostimulation device market segments, market trends and opportunities, and any further data you may need to thrive in the neurostimulation device industry. This neurostimulation device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neurostimulation devices market size has grown rapidly in recent years. It will grow from $6.34 billion in 2023 to $6.98 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The growth observed during the historic period in the field of neurostimulation devices can be attributed to several key factors, including the increasing need for chronic pain management, the aging population, greater awareness and acceptance of these devices as treatment options, and the adoption of a multidisciplinary approach to managing various medical conditions.

The neurostimulation devices market size is expected to see strong growth in the next few years. It will grow to $10.12 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The expected growth in the forecast period in the field of neurostimulation devices can be attributed to various factors, including the adoption of minimally invasive techniques, the expansion of emerging markets, regulatory support and reimbursement initiatives, and the integration of telehealth and remote monitoring in patient care. Noteworthy trends anticipated during the forecast period encompass the development of personalized therapy approaches, the emergence of wearable neurostimulation devices, advancements in programming and connectivity features, and the exploration of combination therapies to enhance treatment outcomes.

The increasing global geriatric population is a significant driver behind the growth of the neurostimulation device market. As the number of elderly individuals continues to rise, so does the prevalence of various neurobiological disorders affecting this demographic. According to a report by the World Health Organization (WHO) in October 2022, it is projected that by 2050, 80% of older people will reside in low- and middle-income countries. Furthermore, the proportion of the world's population over the age of 60 is expected to nearly double from 12% in 2015 to 22% in 2050.

Anticipated growth in the healthcare sector is set to propel the neurostimulation devices market. The healthcare industry is a vast and diverse sector encompassing various organizations, professionals, and institutions dedicated to providing medical services, healthcare products, and overall health maintenance and improvement. Neurostimulation devices play a crucial role in the healthcare industry, particularly in the treatment and management of various neurological conditions and chronic pain. For example, in May 2023, the Office for National Statistics reported that healthcare spending in the UK increased by 9.4% in nominal terms and 9.7% in real terms between 2020 and 2021. The total healthcare expenditure in the UK in 2021 amounted to $367.25 billion (£280.7 billion), with pharmaceutical expenditure reaching $51.84 billion (£39.6 billion). Spending on preventive care also doubled from 2020, reaching $45.93 billion (£35.1 billion). Thus, the burgeoning healthcare industry is a driving force behind the growth of the neurostimulation devices market.

The high costs associated with neurostimulation devices may hinder market growth. For instance, neuromodulation devices for chronic pain management have an average price range of $13,920 to $17,940, while those for epilepsy range from $25,420 to $25,970. Although the construction of neurostimulation devices is similar to cardiac rhythm management devices, they are notably 67% more expensive than the latter.

Innovations in minimally invasive treatments for various neurological disorders are emerging, leading to the development of neurostimulation devices that cause minimal invasion during procedures. For example, Deep Brain Stimulation (DBS) is a minimally invasive surgical procedure used to treat neurological symptoms of Parkinson's disease. DBS involves the use of a neurostimulation device, similar to a heart pacemaker, to deliver precise electrical pulses to specific brain circuits that influence Parkinson's disease symptoms. These electrical pulses block the activity of these circuits, allowing the rest of the brain to function more normally.

Major companies in the neurostimulation devices market are focused on developing advanced technological products like the Eterna Spinal Cord Stimulation (SCS) system for chronic pain treatment. The Eterna SCS system, launched by Abbott Laboratories in December 2022, is the smallest implantable, rechargeable spinal cord stimulator. It features Abbott's proprietary BurstDR stimulation, which replicates natural firing patterns in the brain, providing superior pain relief preferred by 87% of patients over traditional 'tingling' tonic stimulation.

In June 2022, Medtronic plc., an Ireland-based medical device company, acquired Intersect ENT to expand its comprehensive ear, nose, and throat (ENT) portfolio. This acquisition enhances Medtronic's offerings for sinus procedures to improve post-operative outcomes and treat nasal polyps. Intersect ENT is a US-based company specializing in healthcare equipment.

Major companies operating in the neurostimulation devices market include Medtronic PLC, Cyberonics Inc., Boston Scientific Corporation, Abbott Laboratories, Nevro Corporation, Neuronetics Inc., NeuroPace Inc., NeuroSigma Inc., Cochlear Ltd., NDI Medical LLC, Synapse Biomedical Inc., MED-EL, LivaNova PLC, DePuy Synthes Inc., Aleva Neurotherapeutics, BrainsWay, Cortec Corporation, Endonovo Therapeutics Inc., Inspire Medical Systems Inc., The Magstim Company Limited, Mainstay Medical Limited, MicroTransponder Inc., MindMaze, NeuroMetrix, Nexeon MedSystems, Nuvectra, Saluda Medical, SPR Therapeutics Inc., Uro Medical Corporation

North America was the largest region in the global neurostimulation devices market in 2023. Asia-Pacific was the second-largest region in the neurostimulation devices market. The regions covered in the neurostimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the neurostimulation devices market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The neurostimulation devices market consists of sales of spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Neurostimulation Devices Market Characteristics

3. Neurostimulation Devices Market Trends And Strategies

4. Neurostimulation Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Neurostimulation Devices Market Size and Growth

  • 5.1. Global Neurostimulation Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Neurostimulation Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Neurostimulation Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Neurostimulation Devices Market Segmentation

  • 6.1. Global Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Implantable Devices
  • External Devices
  • 6.2. Global Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pain Management
  • Epilepsy
  • Essential Tremor
  • Urinary and Fecal Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson's Disease
  • 6.3. Global Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Rehabilitation Centers
  • Medical Clinics

7. Neurostimulation Devices Market Regional And Country Analysis

  • 7.1. Global Neurostimulation Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Neurostimulation Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Neurostimulation Devices Market

  • 8.1. Asia-Pacific Neurostimulation Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Neurostimulation Devices Market

  • 9.1. China Neurostimulation Devices Market Overview
  • 9.2. China Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Neurostimulation Devices Market

  • 10.1. India Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Neurostimulation Devices Market

  • 11.1. Japan Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Neurostimulation Devices Market

  • 12.1. Australia Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Neurostimulation Devices Market

  • 13.1. Indonesia Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Neurostimulation Devices Market

  • 14.1. South Korea Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Neurostimulation Devices Market

  • 15.1. Western Europe Neurostimulation Devices Market Overview
  • 15.2. Western Europe Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Neurostimulation Devices Market

  • 16.1. UK Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Neurostimulation Devices Market

  • 17.1. Germany Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Neurostimulation Devices Market

  • 18.5. France Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Neurostimulation Devices Market

  • 19.9. Italy Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Neurostimulation Devices Market

  • 20.13. Spain Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Neurostimulation Devices Market

  • 21.1. Eastern Europe Neurostimulation Devices Market Overview
  • 21.2. Eastern Europe Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Neurostimulation Devices Market

  • 22.1. Russia Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Neurostimulation Devices Market

  • 23.1. North America Neurostimulation Devices Market Overview
  • 23.2. North America Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Neurostimulation Devices Market

  • 24.1. USA Neurostimulation Devices Market Overview
  • 24.2. USA Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Neurostimulation Devices Market

  • 25.1. Canada Neurostimulation Devices Market Overview
  • 25.2. Canada Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Neurostimulation Devices Market

  • 26.1. South America Neurostimulation Devices Market Overview
  • 26.2. South America Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Neurostimulation Devices Market

  • 27.1. Brazil Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Neurostimulation Devices Market

  • 28.1. Middle East Neurostimulation Devices Market Overview
  • 28.2. Middle East Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Neurostimulation Devices Market

  • 29.1. Africa Neurostimulation Devices Market Overview
  • 29.2. Africa Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Neurostimulation Devices Market Competitive Landscape And Company Profiles

  • 30.1. Neurostimulation Devices Market Competitive Landscape
  • 30.2. Neurostimulation Devices Market Company Profiles
    • 30.2.1. Medical Clinics
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Medtronic plc
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Cyberonics Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Boston Scientific Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Abbott Laboratories
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Neurostimulation Devices Market Competitive Benchmarking

32. Global Neurostimulation Devices Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Neurostimulation Devices Market

34. Neurostimulation Devices Market Future Outlook and Potential Analysis

  • 34.1 Neurostimulation Devices Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Neurostimulation Devices Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Neurostimulation Devices Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer